1. Home
  2. PED vs IXHL Comparison

PED vs IXHL Comparison

Compare PED & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pedevco Corp.

PED

Pedevco Corp.

HOLD

Current Price

$0.57

Market Cap

49.1M

Sector

Energy

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.45

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PED
IXHL
Founded
N/A
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
49.1M
49.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PED
IXHL
Price
$0.57
$0.45
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
149.8K
23.6M
Earning Date
11-17-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
156.43
N/A
EPS
0.11
N/A
Revenue
$33,244,999.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$305.89
N/A
P/E Ratio
$5.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$0.08
52 Week High
$1.00
$2.25

Technical Indicators

Market Signals
Indicator
PED
IXHL
Relative Strength Index (RSI) 54.81 64.33
Support Level $0.43 $0.35
Resistance Level $0.55 $0.50
Average True Range (ATR) 0.04 0.03
MACD 0.01 0.02
Stochastic Oscillator 83.57 80.58

Price Performance

Historical Comparison
PED
IXHL

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: